GlobeNewswire by notified

Sale of new equity authorised


At a shareholders' meeting of Reykjavík Fibre Network (RFN; Ljósleiðarinn ehf.) today, the following proposal of the company's board of directors for a share capital increase was approved and it is related to the ongoing process of increasing equity as per earlier releases, dated October 22nd and May 2nd 2023. 

The shareholders' meeting agrees to increase the share capital in RFN of up to 3,249,999,513 new shares, each of which shall have a nominal value of ISK 1, or which corresponds to 33.33% of the company's share capital after the increase. The new shares shall belong to the same category of the company's share capital as its existing share capital, and the new shares shall be offered to investors for subscription.

It is also proposed at the shareholders' meeting to increase the share capital in RFN will be started on the basis of the assumptions and data that are currently available to the company's board, the board of OR and the previous records of the board and owners of OR. The final position on the offers will be taken at a shareholders' meeting after their comparison.

The company's board of directors shall determine the tender price and payment terms of the new shares and in what stages the authorization will be used. The current owner of 100% of RFN’s shares, OrkuveitaReykjavíkur (OR; Reykjavík Energy), waives its right of first refusal. 

The proceeds of the share capital increase will, in time, be used for the development of the company's operations and the payment of related debts. Authority of the board to increase the share capital of RFN will be included in the company's articles of association and will be valid until the end of 2024.

Assumptions reinforced

Since the owners of OR – The City of Reykjavík, The Township of Akranes, and The Municipality of Borgarbyggd – approved the share capital increase this spring, OR's board has been working to strengthen the assumptions of a careful and transparent sales process, that will be conducted by Arion Bank's corporate advisory. At a meeting of OR's board on May 31st 2023, the board of OR agreed that "...Arion Bank's advice will be followed to setup a closed sales process and the process should target long-term investors with public interest and parties that bring experience and knowledge beneficial for RFN. The aim will be for diversed ownership among prospective shareholders. The main goal of the sales process is raising the new equity at the highest possible price and in as open and transparent a manner as possible. The proposal will be presented to owner municipalities before a final decision is made." 

That presentation took place on June 15th last. and the CEO of OR will take a final position on the upcoming offers at the shareholders' meeting of RFN, having received a mandate from OR's BoD. 

Sævar Freyr Thráinsson

Mr. Thráinsson is the CEO of Reykjavík Energy, which now controls all RFN’s shares: 

"We believe that investors have faith in the strong and competitive company that Reykjavík Fibre Network is. We have seen investors’ interest in its Green Bonds and thus their faith in the company’s infrastructures, but with the solid underlying operations, RFN will in the future be able to pay yearly dividends to shareholders. Now we are looking for co-owners who are ready to take on the challenges of the future with us. We need to build a new national backhaul fibre-circle to enhance the country's electronic communication security and information security. The advent of 5G requires increased data transmission capacity, and we believe that RFN is a key player in ensuring healthy competition in the telecommunications market in this country. 

It is gratifying how broad the consensus has been among Reykjavík Energy’s owners and within OR's board of directors to expand RFN’s shareholder group with this share capital increase, thus creating an even more competitive company that can offer even more powerful fibre optic connections for Icelandic homes and businesses," says Sævar Freyr. He adds that OR's board has discussed the project in recent meetings, defining the rules of the tender so that they will be well thoroughly considered and determined in advance. 

Sales procedure in the new year

The appointment of a new CEO for RFN has recently been concluded and Mr. Einar Thórarinsson, an experienced manager from the software and technology sector, start at the company September 22nd. Iceland’s Competition Authority’s conclusion on RFN’s purchase of Sýn’s backhaul network is awaited and tendering and sales process of new equity is expected to conclude in 2024. 


Saevar Freyr Thráinsson 
CEO of Reykjavík Energy 

To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

PHAXIAM Therapeutics and Vetophage Announce Strategic Research Collaboration3.10.2023 22:05:00 CEST | Press release

PHAXIAM Therapeutics and Vetophage Announce Strategic ResearchCollaboration Strategic research partnership between PHAXIAM Therapeutics and Vetophage, a biotechnology company specialized in veterinary phage therapy Combining expertise in the research of new phages and phage endolysins that could be applied to human health Exclusive phage and endolysin licensing options in human health for PHAXIAM Therapeutics Lyon (France) and Cambridge (MA, US), October03, 2023 – 10:05pm CEST – PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM) and Vetophage, a company specialized in phage therapy applied to animal health, announce the signature of a long-term strategic research partnership to combine their expertise in the research of new phages and phage-derived proteins (endolysins) in the fight against antimicrobial resistance. Vetophage is a Lyon-based biotechnology company founded in 2017. It develops new tools to detect pathogenic bacteria and alternative solutions to antibiotics based on phages an

Kvika banki hf.: TM Insurance to be sold or listed3.10.2023 21:05:43 CEST | Press release

Following a strategic review at Kvika banki hf. ("Kvika" or "the bank"), the board of directors of Kvika has decided to initiate a process for the sale or listing of its insurance subsidiary TM tryggingar hf. ("TM"). The decision is in line with the bank's vision, where emphasis is placed on simplifying the group's operations and strengthening Kvika's traditional banking activities, in accordance with the bank's goal to increase competition and simplify its customers' finances. Following the divestment of TM, Kvika's main operations will be focused on commercial- and investment banking, along with asset management. It is expected that Kvika's capital base will grow significantly following the divestment of TM, enabling the bank to pursue internal growth opportunities across Kvika's business segments. Increased capital will, among other things, enable the bank to strengthen its market position, in both retail and corporate lending, and increase the risk diversification of its loan book.

Policane® Natural Sweetener Found to Have Low Glycemic Index3.10.2023 20:06:38 CEST | Press release

OCALA, Fla., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Policane®, a natural sweetener made from sugar cane juice in a patented process, has been found to have a low glycemic index (GI) in a study by IFP Suisse SA. According to the study Policane® has a GI of 51.7+/- 3.66. The study also found that Policane® had a 42% lower GI than white sugar. In its conclusion, the study recommends for Policane® a low glycaemic index product classification under International Standard ISO26642. “We are excited to share the results of this study, providing that Policane® is a low-GI sweetener,” said Jorge Enrique Gonzalez, Manager and CEO at PoliCane Co., LLC. “Policane® retains the best parts of the sugar cane stripped away in refined sugar. Policane® is a natural and sustainable sweetener that the world needs.” Policane® is currently produced under license in Costa Rica and can be used in recipes for all sweetened food and beverages, including baked goods, coffee, tea, colas, sauces, ketchup and desserts. Fo

Nokia Corporation: Repurchase of own shares on 03.10.20233.10.2023 20:00:00 CEST | Press release

Nokia Corporation Stock Exchange Release 3 October 2023 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 03.10.2023 Espoo, Finland – On 3 October 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL344,5423.53CEUX39,5413.54AQEU1,3923.53TQEX14,5253.55Total400,0003.53 * Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 5 April 2022 started on 2 January 2023

Adevinta ASA – Procedures established in response to receipt of non-binding indicative proposal3.10.2023 19:30:00 CEST | Press release

Oslo, 3 October 2023 – Adevinta ASA (“Adevinta” or the “Company”) refers to the stock exchange announcement on 21 September 2023 regarding receipt of a non-binding indicative proposal (the “Proposal”) from a consortium led by Permira and Blackstone, with involvement of the Company’s two main shareholders, regarding a potential offer for all shares of the Company. In response to shareholder enquiries, the Company wants to communicate the procedures it is following in response to the Proposal. Immediately upon receipt of the Proposal, the Company’s board of directors established a special committee comprising the five independent directors on the Company’s board. The special committee is representing the Company in all aspects relating to the Proposal. The directors who are representatives of the three main shareholders of the Company are not involved in the Company’s deliberations and decisions. The independent committee is actively engaging in the Proposal in line with applicable regul